Changes in the stria vascularis of the guinea pig due to cis-platinum

Archives of Oto-rhino-laryngology
R A Tange, V D Vuzevski

Abstract

The microscopical and ultramicroscopical changes in the stria vascularis due to cis-diamminedichloroplatinum II (DDP) were studied. Sixteen healthy adult guinea pigs were used for the experiment. A standard dosage DDP (1.5 mg/kg/d) was administered over a period of 5-20 days. A clear degeneration pattern was found (ranging from no changes to cystic degeneration with protrusion of marginal cells followed by loss of marginal cells). DDP seems to be especially toxic for marginal cells in stria vascularis in the guinea pig.

References

Aug 1, 1975·Toxicology and Applied Pharmacology·R W FleischmanU Schaeppi
Jun 23, 1979·British Medical Journal·C J Williams, J M Whitehouse
Jan 1, 1978·Clinical Toxicology·L HelsonE Cvitkovic
Jan 1, 1977·Acta Oto-laryngologica·R BrummettR Richter
Mar 1, 1981·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·S KomuneJ B Snow
Jan 1, 1980·Archives of Oto-rhino-laryngology·D Bagger-SjöbäckJ Schacht
Jul 1, 1981·The Journal of Laryngology and Otology·L P Rybak
Oct 1, 1981·Archives of Otolaryngology·S Komune, J B Snow
Mar 1, 1982·Acta Oto-laryngologica·Y NakaiA Morimoto
Jan 1, 1980·Archives of Oto-rhino-laryngology·R A Tange, E H Huizing

❮ Previous
Next ❯

Citations

Jan 1, 1985·Archives of Oto-rhino-laryngology·K Böheim, E Bichler
Jan 1, 1985·Archives of Oto-rhino-laryngology·R A TangeR J van der Hulst
Aug 2, 2008·Apoptosis : an International Journal on Programmed Cell Death·Chul-Ho KimHaNeul Lee
Oct 13, 2011·Neurotoxicity Research·Issam Saliba, Fouad El Fata
Aug 1, 1990·Toxicology Letters·G LaurellB Rydqvist
Mar 1, 1989·Hearing Research·G Laurell, B Engström
Dec 1, 1992·Hearing Research·M Lavigne-Rebillard, D Bagger-Sjöbäck
Nov 28, 1997·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·J A KaltenbachD L Burgio
Oct 18, 2000·Hearing Research·N TsukasakiL P Rybak
Sep 2, 2003·Hearing Research·Bruno SergiAnna Rita Fetoni
Nov 6, 2003·Hearing Research·Steven SluyterGuido F Smoorenburg
Nov 27, 1999·Hearing Research·K C CampbellL F Hughes
Mar 14, 2000·Hearing Research·S A AlamT Takasaka
Jan 30, 2007·Audiology & Neuro-otology·Göran LaurellBarbara Canlon
Aug 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Guiscardo LoritoHenryk Skarzynski
Jan 1, 1991·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·T Koch, B Gloddek
Aug 22, 2012·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Sofia WaissbluthSam J Daniel
Jan 1, 1985·Acta Oto-laryngologica. Supplementum·R A Tange
Jan 1, 1997·Acta Oto-laryngologica·S MiettinenE Laurikainen
Jan 1, 1987·Acta Oto-laryngologica. Supplementum·B EngströmD Bagger-Sjöbäck
Jan 1, 1991·Acta Oto-laryngologica·G Laurell, D Bagger-Sjöbäck
Jan 13, 2009·International Journal of Radiation Oncology, Biology, Physics·Charlotte L ZuurCoen R Rasch
Jul 1, 1986·American Journal of Otolaryngology·M Anniko, A Sobin
Jan 1, 1986·Acta Oto-laryngologica·G Laurell, E Borg
Aug 21, 2007·International Journal of Pediatric Otorhinolaryngology·Mai Thy TruongKay W Chang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.